Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
D000681:Amylases / Q000097:blood; D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage*; D044469:Racial Groups; D012075:Remission, Spontaneous; D014511:Uremia / Q000139:chemically induced; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000008:administration & dosage*
D014527:Uric Acid; D014750:Vincristine; D000681:Amylases; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin